Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.2430
+0.0064 (2.70%)
At close: Feb 23, 2026, 4:00 PM EST
0.2479
+0.0049 (2.02%)
After-hours: Feb 23, 2026, 4:32 PM EST
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $11 million as of February 23, 2026. Its market cap has decreased by -63.55% in one year.
Market Cap
11.00M
Enterprise Value
11.04M
1-Year Change
-63.55%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $11.00M, a decrease of -96.23%. That is a compound annual growth rate of -27.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 10.71M | -19.05% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 11.92M |
| Kairos Pharma | 11.56M |
| Iterum Therapeutics | 11.20M |
| Soligenix | 11.09M |
| Phio Pharmaceuticals | 11.09M |
| Imunon | 10.95M |
| KALA BIO | 10.73M |
| OSR Holdings | 10.65M |